Home4DX • ASX
add
4DMedical Ltd
Previous close
$0.50
Day range
$0.53 - $0.56
Year range
$0.41 - $0.83
Market cap
217.02M AUD
Avg Volume
953.90K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
(AUD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 1.48M | 1,172.70% |
Operating expense | 12.56M | 11.42% |
Net income | -10.19M | -33.78% |
Net profit margin | -687.84 | 89.49% |
Earnings per share | — | — |
EBITDA | -11.09M | -5.51% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 30.61M | -56.01% |
Total assets | 120.02M | 29.16% |
Total liabilities | 49.09M | 128.71% |
Total equity | 70.93M | — |
Shares outstanding | 410.53M | — |
Price to book | 2.91 | — |
Return on assets | -23.28% | — |
Return on capital | -36.73% | — |
Cash Flow
Net change in cash
(AUD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -10.19M | -33.78% |
Cash from operations | -8.06M | 8.54% |
Cash from investing | -339.48K | -21.29% |
Cash from financing | -233.98K | -101.11% |
Net change in cash | -8.64M | -172.48% |
Free cash flow | -5.43M | 13.25% |
About
4DMedical is a medical technology company, based in Australia and the United States.
4DMedical created X-ray Velocimetry Lung Ventilation Analysis Software based on the company's proprietary XV Technology. XV Technology uses patented algorithms adapted from advanced aerodynamics research to process and enhance X-ray and Computed Tomography images. Airflow is measured throughout all regions of the lung, across all phases of the breath—providing clinicians with quantitative lung ventilation data in a report.
4DMedical has commercialized its XV Technology via a Software as a Service model, where patients are scanned using existing imaging equipment and analyzed by 4DMedical remotely. Airflow is measured throughout all regions of the lung, across all phases of the breath, delivering the capability to quantify regional lung function throughout the respiratory cycle, at every location within the lung. The lung function data is provided to clinicians and patients in a report that includes color-coded lung images. This approach enables the detection of subtle functional losses before lung structure is irreversibly effected by the disease. Wikipedia
Founded
2013
Website
Employees
145